Menu
Menu
These doctor-prescribed weekly treatments are personalized medications known as Semaglutide or GLP-1, and dual acting GLP-1/GIP tailor-made for each patient. Combining the actions of GLP-1 receptor agonists with GIP (glucose-dependent insulinotropic polypeptide) offers a dual approach in managing weight and improving glycemic control.
Whenever we consume food, specific hormones, including GLP-1 and GIP, are naturally released in our body, triggering a sensation of fullness. These medications target the brain, emulating that sense of fullness, curbing appetite, delaying stomach emptying, and ultimately reducing your daily calorie intake.
Furthermore, your body has a “set point,” the weight range at which your body naturally tends to stabilize. The treatment plan aims to establish a new, lower set point after you’ve reached your desired weight. This innovative approach is designed to help maintain long-term weight management more effectively.
It’s essential to note that approximately 70% of American adults grapple with obesity or overweight conditions, which pose significant health risks. These conditions are associated with leading causes of mortality, including heart disease, stroke, and diabetes, and are linked to an elevated risk of certain types of cancer.
By addressing weight issues with this comprehensive treatment, patients have a promising avenue towards improving their health and reducing the risks associated with obesity and overweight conditions..
Losing 5% to 10% of body weight through dietary adjustments and increased physical activity has been shown to reduce the risk of cardiovascular disease in adults dealing with obesity or being overweight.
Compounded Semaglutide is a cutting-edge treatment in weight management, functioning as a GLP-1 receptor agonist to mimic the body’s natural hormones that regulate hunger and satiety. By enhancing the feeling of fullness and reducing appetite,
Semaglutide effectively aids in lowering calorie intake and promoting weight loss. It works by slowing gastric emptying and influencing brain pathways responsible for hunger signals, thereby assisting patients in achieving and maintaining a healthier weight.
Its use in compounded form allows for personalized dosing, tailored to meet the specific needs and health goals of individuals struggling with obesity or overweight conditions, providing a targeted approach to weight loss.
Compounded GLP-1/GIP represents a revolutionary advancement in weight management, combining the benefits of GLP-1 receptor agonism with GIP (glucose-dependent insulinotropic polypeptide) action.
This dual mechanism enhances the body’s natural response to food intake, significantly reducing hunger and promoting a feeling of fullness. By targeting two critical pathways involved in appetite regulation and insulin secretion, Tirzepatide facilitates substantial weight loss and improves glycemic control.
The compounded formulation allows for personalized dosing, This innovative approach addresses both obesity and related metabolic disorders, offering a promising solution for those seeking to achieve and maintain a healthier weight.
This injectable medication bears the official seal of approval for the chronic management of weight in adults. It's not limited to obesity but is also efficacious for individuals dealing with overweight conditions.
Semaglutide functions by reducing the speed at which your stomach empties while also sending early signals to your brain, promoting a quicker sense of fullness. This dual-action process effectively reduces cravings and prevents excessive eating, leading to a decrease in appetite and food intake, ultimately resulting in weight loss.
It assists in managing your appetite and cravings, laying the foundation for your success. While the benefits may differ, potential outcomes include weight loss, enhanced fertility, smoking cessation, cardiovascular advantages, and neuroprotective treatment for PCOS.
The Ultimate Weight Loss Solution Has Arrived! Experience the game-changing medication that’s redefining the weight loss industry. Custom-blended for your success, it partners with your body to support effortless weight loss.
Recent studies have shown phenomenal outcomes. Over a 68-week period, participants lost an average of 35lbs or approximately 15% of their body weight. With continued use, you could potentially lose up to 30% of your body weight!
*Source: Chao AM, Tronieri JS, Amaro A, Wadden TA. Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations. Drug Des Devel Ther. 2022 Dec 29;16:4449-4461. doi: 10.2147/DDDT.S365416. PMID: 36601368; PMCID: PMC9807016.
Book your appointment today and explore the effectiveness of our physician-approved weight loss medication!
As a special offer for parishioners of Saint John the Baptist Catholic Parish, receive your in-clinic consultation for free ($150 value)!
Just fill in the form below and the clinic will be in touch answer any questions you have and schedule your consultation!
As a special offer for parishioners of Heart of Jesus Church, receive your in-clinic consultation for free ($150 value)!
Just fill in the form below and the clinic will be in touch answer any questions you have and schedule your consultation!